ReEmerge, Inc. Exits Stealth with Oversubscribed $37M Series A to Challenge the Limitations of Chronic Cognitive Impairment Caused by Brain Injuries

Summary

ReEmerge, Inc. exited stealth mode and raised an oversubscribed $37M Series A to develop Cognitive Network Restoration Therapy (CNRT) technology for treating chronic cognitive impairment caused by brain injuries. The technology targets brain networks involved in executive function to restore cognitive recovery years after injury.